Rapid Analysis of Outcomes Using the Systemic Anti-Cancer Therapy (SACT) Dataset

Abstract We audited the accuracy of the Systemic Anti-Cancer Therapy dataset as a resource for rapid analysis of outcomes for patients, in this example, receiving Cancer Drug Fund funded monoclonal antibodies to treat metastatic colorectal cancer. We concluded that the Systemic Anti-Cancer Therapy d...

Full description

Saved in:
Bibliographic Details
Published in:Clinical oncology (Royal College of Radiologists (Great Britain)) 2017-07, Vol.29 (7), p.e134-e136
Main Authors: Pathak, R, Wallington, M, Saunders, C, Braun, M, Mullamitha, S, Wilson, G, Hasan, J, Dodwell, D, Bomb, M, Saunders, M
Format: Article
Language:English
Subjects:
Antineoplastic Agents - therapeutic use
Cancer Drug Fund
CDF
cetuximab
Cetuximab - therapeutic use
colorectal
Colorectal Neoplasms - drug therapy
Female
Hematology, Oncology and Palliative Medicine
Humans
Male
Radiology
SACT
Systemic Anti-Cancer Therapy dataset
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract We audited the accuracy of the Systemic Anti-Cancer Therapy dataset as a resource for rapid analysis of outcomes for patients, in this example, receiving Cancer Drug Fund funded monoclonal antibodies to treat metastatic colorectal cancer. We concluded that the Systemic Anti-Cancer Therapy dataset is a potentially valuable resource for rapidly determining survival outcome for patients treated with chemotherapy.
ISSN:0936-6555
1433-2981
DOI:10.1016/j.clon.2017.02.011